EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis






Research in Microbiology 140(4-5): 301-309

Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis

Pyrazinamide (PZA) is one of the most important drugs in modern chemotherapy of tuberculosis. Since PZA is active only at an acid pH, testing the susceptibility of Mycobacterium tuberculosis to PZA is difficult and timeconsuming. Therefore, we evaluated the BACTEC system for rapid testing of PZA susceptibility at pH 6. A total of 91 M. tuberculosis strains and 2 different strains of M. bovis BCG were screened for susceptibility to PZA. Each strain was tested in special 7H12 broth supplemented with polyoxyethylene stearate containing 25, 50 and 100 micrograms PZA/ml. Strains resistant to 100 micrograms/ml were retested against 25-100 micrograms/ml and at an extended range of PZA concentrations from 200-6,400 micrograms/ml. The MIC was determined with all strains within 4-20 (mean 7) days. Of the 77 susceptible strains, based on the pyrazinamidase test, MIC were less than or equal to 25 micrograms/ml for 34 strains, 50 for 38 and 100 for 2 strains. Three pyrazinamidase-positive strains had still higher MIC, 1 at 800 and 2 at 3,200 micrograms/ml. PZA-resistant strains had MIC of 800 or greater. Monoresistance to PZA has not been detected to date. The clear bimodal distribution of MIC in this method could enable the routine clinical microbiology laboratory to perform PZA susceptibility testing as easily as the 4 drugs now tested in the BACTEC system.

(PDF same-day service: $19.90)

Accession: 041172703

PMID: 2508202

DOI: 10.1016/0923-2508(89)90022-3



Related references

Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Antimicrobial Agents and ChemoTherapy 30(6): 852-855, 1986

Radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis in egg-yolk-enriched BACTEC 12A medium. Antimicrobial Agents and ChemoTherapy 32(1): 125-127, 1988

Radiometric method for pyrazinamide susceptibility testing of mycobacterium tuberculosis using egg yolk enriched bactec 12a medium. Abstracts of the Annual Meeting of the American Society for Microbiology 87: 136, 1987

Radiometric pyrazinamide susceptibility testing of mycobacterium tuberculosis. Abstracts of the Annual Meeting of the American Society for Microbiology 83: C226, 1983

Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide by the non-radiometric BACTEC MGIT 960 system. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 155, 2000

Evaluation of a rapid radiometric method for drug susceptibility testing of mycobacterium tuberculosis. Journal of Clinical Microbiology 13(5): 908-912, 1981

Multicenter evaluation of a nonweekend reading schedule for radiometric pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Journal of Clinical Microbiology 40(10): 3753-3756, 2002

Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. Journal of Clinical Microbiology 42(3): 1109-1114, 2004

Primary isolation preliminary identification and drug susceptibility testing of the mycobacterium tuberculosis complex by a rapid radiometric method. Bulletin of the International Union Against Tuberculosis 57(1): 54, 1982

Rapid colorimetric pyrazinamide susceptibility testing of Mycobacterium tuberculosis. International Journal of Tuberculosis and Lung Disease 20(4): 462-467, 2016